Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Liquid Biopsy and Cancer Interception Group, |
RCV003129617 | SCV003806312 | uncertain significance | Squamous cell carcinoma | 2022-06-06 | criteria provided, single submitter | research | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004801314 | SCV005423196 | uncertain significance | not specified | 2024-10-30 | criteria provided, single submitter | clinical testing | Variant summary: SERPINA1 c.844G>A (p.Gly282Arg) results in a non-conservative amino acid change located in the Serpin domain (IPR023796) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251486 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.844G>A has been reported in the literature in individuals affected with Alpha-1-Antitrypsin Deficiency (Silva_2016, Wiesemann_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Alpha-1-Antitrypsin Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. This variant is also known as W Springfield and p.Gly258Arg. The following publications have been ascertained in the context of this evaluation (PMID: 27296815, 36367950). ClinVar contains an entry for this variant (Variation ID: 2431084). Based on the evidence outlined above, the variant was classified as uncertain significance. |